What is Lambert-Eaton myasthenic syndrome

TL;DR: Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder that disrupts the communication between nerves and muscles, leading to muscle weakness and fatigue. It is often caused by the body’s immune system mistakenly attacking the voltage-gated calcium channels at the nerve endings, which prevents the release of the chemicals needed to trigger muscle contraction.

What exactly is Lambert-Eaton myasthenic syndrome?

Lambert-Eaton myasthenic syndrome is a rare neuromuscular junction disorder. In a healthy body, nerves release a chemical messenger called acetylcholine to signal muscles to contract. In individuals with Lambert-Eaton myasthenic syndrome, the body produces autoantibodies that interfere with this process, specifically by targeting the voltage-gated calcium channels. This blockage means that muscles do not receive the full signal to move, resulting in profound muscle weakness, particularly in the limbs. At DiseaseMaps.org, we currently support a growing community of 23 people living with Lambert-Eaton myasthenic syndrome who share their experiences navigating this complex condition.

What are the two main types of Lambert-Eaton myasthenic syndrome?

Clinicians generally categorize Lambert-Eaton myasthenic syndrome into two distinct forms based on the underlying trigger:

• Paraneoplastic LEMS: This form is associated with an underlying malignancy, most commonly small-cell lung cancer. In these cases, the body’s immune response against the tumor cells cross-reacts with healthy nerve tissue. Approximately 50–60% of LEMS cases are paraneoplastic.


• Non-paraneoplastic (Autoimmune) LEMS: This form occurs independently of cancer. It is a primary autoimmune condition where the immune system malfunctions without the presence of a tumor. This type typically has a slower progression and is often associated with other autoimmune conditions like thyroid disease or vitiligo.

Who is typically affected by this condition?

Lambert-Eaton myasthenic syndrome is exceptionally rare, with an estimated prevalence of approximately 1 in 100,000 to 1 in 250,000 people globally. While it can occur at any age, the paraneoplastic form is most frequently diagnosed in adults over the age of 50, often correlating with the age of onset for small-cell lung cancer. The non-paraneoplastic form can appear at any age, including in childhood. There is no significant geographic clustering, and both men and women are affected, though some studies suggest a slightly higher prevalence in males, likely due to the higher incidence of smoking-related lung cancer in that demographic.

How is Lambert-Eaton myasthenic syndrome different from other conditions?

Patients are often confused between Lambert-Eaton myasthenic syndrome and Myasthenia Gravis (MG). While both cause muscle weakness, they are distinct. In LEMS, weakness is usually most severe in the legs and improves temporarily with exercise (the "facilitation" phenomenon). Conversely, in MG, weakness often starts in the eyes or face and worsens with sustained activity. Additionally, individuals with Lambert-Eaton myasthenic syndrome frequently experience autonomic symptoms, such as dry mouth, constipation, and blurred vision, which are less common in other neuromuscular disorders.

Next steps

• Consult a Neurologist: Seek evaluation from a neuromuscular specialist who has experience with rare autoimmune conditions.


• Cancer Screening: If you are diagnosed with Lambert-Eaton myasthenic syndrome, your physician will prioritize comprehensive imaging to rule out or identify underlying malignancy.


• Connect with Peers: Join the community at DiseaseMaps.org to share experiences with the 23 other members currently managing this condition.


• Maintain a Symptom Diary: Track your muscle strength and autonomic symptoms to help your care team adjust treatment plans effectively.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Lambert-Eaton myasthenic syndrome (ORPHA:560).


• NIH GARD: Genetic and Rare Diseases Information Center - Lambert-Eaton myasthenic syndrome overview.


• OMIM: Online Mendelian Inheritance in Man - Lambert-Eaton myasthenic syndrome (Entry #605031).


• Myasthenia Gravis Foundation of America (MGFA): Resources and patient support for LEMS.